Ceritinib (LDK378) prevents bone loss via suppressing Akt and NF-κB-induced osteoclast formation

Wenxin He(Shanghai Jiao Tong University), An Qin(Shanghai Ninth People's Hospital)
Frontiers in Endocrinology
November 8, 2022
Cited by 1


Related Papers